CORRELATION OF MONOCLONAL-ANTIBODY PHENOTYPING AND CELLULAR DNA CONTENT IN NON-HODGKINS-LYMPHOMA - THE SOUTHEASTERN CANCER STUDY-GROUP EXPERIENCE

被引：0
|
作者：
WAIN, SL
BRAYLAN, RC
BOROWITZ, MJ
机构：
[1] DUKE UNIV, MED CTR, DEPT PATHOL, BOX 3712, DURHAM, NC 27710 USA
[2] UNIV FLORIDA, GAINESVILLE, FL 32611 USA
来源：
CANCER | 1987年 / 60卷 / 10期
关键词：
D O I：
10.1002/1097-0142(19871115)60:10<2403::AID-CNCR2820601009>3.0.CO;2-O
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：2403 / 2411
页数：9
相关论文
共 40 条
  • [31] IMPACT OF INTERFERON AT INDUCTION CHEMOTHERAPY AND MAINTENANCE TREATMENT FOR MULTIPLE-MYELOMA - PRELIMINARY-RESULTS OF A MULTICENTER STUDY BY THE ITALIAN NON-HODGKINS-LYMPHOMA COOPERATIVE STUDY-GROUP (NHLCSG)
    CAPNIST, G
    VESPIGNANI, M
    SPRIANO, M
    DAMASIO, E
    CRAVIOTTO, L
    RIZZOLI, V
    CONTU, A
    OLMEO, N
    TEDESCHI, L
    FABRIS, P
    CHISESI, T
    ACTA ONCOLOGICA, 1994, 33 (05) : 527 - 529
  • [32] MULTI-INSTITUTION STUDY OF NON-HODGKINS LYMPHOMAS USING FROZEN SECTION IMMUNOPEROXIDASE - THE SOUTHEASTERN CANCER GROUP EXPERIENCE
    BOROWITZ, MJ
    NEWBY, S
    COLLINS, R
    BRYNES, R
    COUSAR, J
    WHITCOMB, C
    CRISSMAN, J
    BYRNE, G
    LABORATORY INVESTIGATION, 1983, 48 (01) : A10 - A10
  • [33] PHASE-II TRIAL OF M-AMSA THERAPY IN REFRACTORY HODGKINS-DISEASE AND NON-HODGKINS-LYMPHOMA - CANCER AND LEUKEMIA GROUP-B STUDY 7972
    RYBAK, ME
    ANDERSON, JR
    POULIN, RF
    AMREIN, PC
    CANELLOS, GP
    GOTTLIEB, AJ
    CANCER TREATMENT REPORTS, 1986, 70 (10): : 1233 - 1234
  • [34] PHASE-II TRIAL OF IFOSFAMIDE AND MESNA IN PREVIOUSLY TREATED PATIENTS WITH NON-HODGKINS-LYMPHOMA - CANCER AND LEUKEMIA GROUP-B STUDY-8552
    CASE, DC
    ANDERSON, J
    ERVIN, TJ
    GOTTLIEB, A
    HEMATOLOGICAL ONCOLOGY, 1991, 9 (4-5) : 189 - 196
  • [35] PHASE-II TRIAL OF ETOPOSIDE AND CISPLATIN IN PATIENTS WITH REFRACTORY AND RELAPSED NON-HODGKINS-LYMPHOMA - CANCER AND LEUKEMIA GROUP-B STUDY-8351
    RYBAK, ME
    ANDERSON, J
    KAPLAN, R
    BUDMAN, DR
    VINCIGUERRA, V
    GOTTLIEB, AJ
    MEDICAL AND PEDIATRIC ONCOLOGY, 1993, 21 (06): : 441 - 445
  • [36] PHASE-II TRIAL OF IFOSFAMIDE MESNA AND MITOXANTRONE IN PREVIOUSLY TREATED PATIENTS WITH NON-HODGKINS-LYMPHOMA - CANCER AND LEUKEMIA GROUP-B STUDY 8753
    CASE, DC
    SANTARELLI, MT
    CAREY, RW
    ANDERSON, J
    GOTTLIEB, A
    MEDICAL AND PEDIATRIC ONCOLOGY, 1992, 20 (04): : 325 - 329
  • [37] A PHASE-II STUDY OF RECOMBINANT INTERLEUKIN-2 WITH OR WITHOUT RECOMBINANT INTERFERON-BETA IN NON-HODGKINS-LYMPHOMA - A STUDY OF THE CANCER AND LEUKEMIA GROUP-B
    DUGGAN, DB
    SANTARELLI, MT
    ZAMKOFF, K
    LICHTMAN, S
    ELLERTON, J
    COOPER, R
    POIESZ, B
    ANDERSON, JR
    BLOOMFIELD, CD
    PETERSON, BA
    GOTTLIEB, AJ
    JOURNAL OF IMMUNOTHERAPY, 1992, 12 (02): : 115 - 122
  • [38] SIMILAR EFFICACY OF 6 AND 18 MONTHS OF THERAPY WITH 4 DRUGS (COMP) FOR LOCALIZED NON-HODGKINS LYMPHOMA OF CHILDREN - A REPORT FROM THE CHILDRENS CANCER STUDY-GROUP
    MEADOWS, AT
    SPOSTO, R
    JENKIN, RDT
    KERSEY, JH
    CHILCOTE, RR
    SIEGEL, SE
    COCCIA, PF
    ROSENSTOCK, J
    PRINGLE, KC
    STOLAR, CJ
    KADIN, ME
    HAMMOND, GD
    JOURNAL OF CLINICAL ONCOLOGY, 1989, 7 (01) : 92 - 99
  • [39] TREATMENT OF LOW-GRADE NON-HODGKINS-LYMPHOMA WITH CONTINUOUS-INFUSION OF LOW-DOSE RECOMBINANT INTERLEUKIN-2 IN COMBINATION WITH THE B-CELL-SPECIFIC MONOCLONAL-ANTIBODY CLB-CD19
    VLASVELD, LT
    HEKMAN, A
    VYTHDREESE, FA
    MELIEF, CJM
    SEIN, JJ
    VOORDOUW, AC
    DELLEMIJN, TAM
    RANKIN, EM
    CANCER IMMUNOLOGY IMMUNOTHERAPY, 1995, 40 (01) : 37 - 47
  • [40] A PHASE-II TRIAL OF HUMAN RECOMBINANT INTERLEUKIN-2 ADMINISTERED AS A 4-DAY CONTINUOUS-INFUSION FOR CHILDREN WITH REFRACTORY NEUROBLASTOMA, NON-HODGKINS-LYMPHOMA, SARCOMA, RENAL-CELL CARCINOMA, AND MALIGNANT-MELANOMA - A CHILDRENS CANCER GROUP STUDY
    BAUER, M
    REAMAN, GH
    HANK, JA
    CAIRO, MS
    ANDERSON, P
    BLAZAR, BR
    FRIERDICH, S
    SONDEL, PM
    CANCER, 1995, 75 (12) : 2959 - 2965
1234